<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01910584</url>
  </required_header>
  <id_info>
    <org_study_id>First-GYN-SYSU-2012</org_study_id>
    <nct_id>NCT01910584</nct_id>
  </id_info>
  <brief_title>Quality of Life and Sexual Function of the Novasure Endometrial Ablation in Menorrhagia</brief_title>
  <official_title>Prospective Study of the Influence on Quality of Life and Sexual Function of the Novasure Endometrial Ablation in the Treatment of Menorrhagia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shu-Qin Chen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>First Affiliated Hospital, Sun Yat-Sen University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to investigate the influence on the quality of life and sexual
      function before, 6 month and one year after Novasure Endometrial Ablation in the treatment of
      Menorrhagia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      patients diagnosed menorrhagia scheduled for Novasure Endometrial Ablation because of
      menorrhagia between november, 2012 and november, 2014 are enrolled to this study.

      patients are asked to complete preoperative questionnaires considering Health Related Quality
      of Life questionnaire(HRQoL) and sexual Female Sexual Functioning Index questionnaire(FSFI).
      Same questionnaires will also be completed six months and one year after operation.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>November 2012</start_date>
  <completion_date type="Anticipated">November 2015</completion_date>
  <primary_completion_date type="Anticipated">November 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Quality of life and Sexual Function before, six month and one year after the Novasure Endometrial Ablation</measure>
    <time_frame>one year after Novasure Endometrial Ablation</time_frame>
    <description>Quality of life assessed with Health Related Quality of Life questionnaire(HRQoL) before, six month and one year after the Novasure Endometrial Ablation; Sexual Function measured with Female Sexual Functioning Index questionnaire(FSFI) before, six month and one year after the Novasure Endometrial Ablation</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Quality of Life</condition>
  <condition>Sexual Activity</condition>
  <arm_group>
    <arm_group_label>Novasure treated group</arm_group_label>
    <description>patients diagnosed menorrhea were treated with novasure endometrial ablation</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Novasure endometrial ablation</intervention_name>
    <description>Novasure endometrial ablation is the second generation endometrial ablation treatment aimed to cure the dysfunctional uterine bleeding(DUB),including menorrhagia.</description>
    <arm_group_label>Novasure treated group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        100 patients diagnosed menorrhagia scheduled for Novasure endometrial ablation in The First
        Affiliated Hospital between November 2012 and November 2015
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  clinical diagnosis of menorrhagia

          -  family complete

          -  normal endometrial pathology

          -  had not been referred specifically for surgery

          -  with normal uterine cavity

        Exclusion Criteria:

          -  pregnancy or demand to preserve fertility

          -  acute reproductive tract inflammation or urinary tract inflammation

          -  pathology demonstrate endometrial cancer or precancerous change

          -  acute pelvic inflammation

          -  intrauterine device(IUD) in uterus

          -  depth of uterine cavity less than 4cm or more than 10cm

          -  pathologic myometrium( such as history of Hysteromyomectomy or classical cesarean
             section)
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shu-Zhong Yao, PhD &amp; MD</last_name>
    <role>Study Director</role>
    <affiliation>First Affiliated Hospital, Sun Yat-Sen University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Shu-Qin Chen, PhD &amp; MD</last_name>
    <phone>+862087332200</phone>
    <phone_ext>8342</phone_ext>
    <email>chenshuqin1021@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Sun yat-sen University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510080</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shu-Qin Chen, PhD &amp; M.D</last_name>
      <phone>+862087332200</phone>
      <phone_ext>8342</phone_ext>
      <email>chenshuqin1021@163.com</email>
    </contact>
    <contact_backup>
      <last_name>Jin-bo Li, M.D</last_name>
      <phone>+862087332200</phone>
      <phone_ext>8342</phone_ext>
      <email>bobolee2004@aliyun.com</email>
    </contact_backup>
    <investigator>
      <last_name>Jin-bo Li, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>September 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 20, 2013</study_first_submitted>
  <study_first_submitted_qc>July 25, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 29, 2013</study_first_posted>
  <last_update_submitted>July 25, 2013</last_update_submitted>
  <last_update_submitted_qc>July 25, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 29, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>First Affiliated Hospital, Sun Yat-Sen University</investigator_affiliation>
    <investigator_full_name>Shu-Qin Chen</investigator_full_name>
    <investigator_title>associate professor of gynaecology and obstetrics</investigator_title>
  </responsible_party>
  <keyword>quality of life</keyword>
  <keyword>sexual activity</keyword>
  <keyword>Novasure endometrial ablation</keyword>
  <keyword>menorrhagia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Menorrhagia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

